|
US5744500A
(en)
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
CA2496867A1
(en)
|
2002-08-28 |
2004-03-11 |
Hollis-Eden Pharmaceuticals, Inc. |
Therapeutic treatment methods
|
|
US8058442B2
(en)
*
|
2002-11-07 |
2011-11-15 |
Technion Research And Development Foundation Ltd. |
Neuroprotective iron chelators and pharmaceutical compositions comprising them
|
|
ES2588780T3
(es)
|
2002-11-15 |
2016-11-04 |
Teva Pharmaceutical Industries Limited |
Uso de rasagilina con o sin riluzol para el tratamiento de la esclerosis lateral amiotrófica
|
|
JP2007512319A
(ja)
*
|
2003-11-25 |
2007-05-17 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
心臓血管障害及び疾患を治療するための組成物及び方法
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
CA2574925A1
(en)
*
|
2004-07-26 |
2006-02-09 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical dosage forms including rasagiline
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
EP1807118B8
(en)
|
2004-09-29 |
2014-04-23 |
Harbor Therapeutics, Inc. |
Steroid analogs and characterization and treatment methods
|
|
DK1848415T3
(da)
*
|
2005-02-17 |
2013-07-08 |
Teva Pharma |
Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
|
|
KR20170023211A
(ko)
|
2005-02-23 |
2017-03-02 |
테바 파마슈티컬 인더스트리즈 리미티드 |
함량 균일성이 개선된 라사길린 제형
|
|
US8263655B2
(en)
*
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
WO2007061717A2
(en)
|
2005-11-17 |
2007-05-31 |
Teva Pharmaceutical Industries, Ltd. |
Methods for isolating propargylated aminoindans
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
CN103142570A
(zh)
|
2005-12-09 |
2013-06-12 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
低剂量Ladostigil 用于神经保护的用途
|
|
AU2007217349B9
(en)
|
2006-02-21 |
2013-06-27 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of Multiple System Atrophy
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
JP5769923B2
(ja)
|
2006-04-03 |
2015-08-26 |
テバ ファーマシューティカル インダストリーズ リミティド |
レストレスレッグス症候群の治療のためのラサギリンの使用
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
CN101600346B
(zh)
*
|
2006-12-14 |
2013-08-21 |
泰华制药工业有限公司 |
雷沙吉兰的单宁酸盐
|
|
ATE528989T1
(de)
*
|
2006-12-14 |
2011-11-15 |
Teva Pharma |
Kristalline feste rasagilin-base
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
WO2009032273A1
(en)
*
|
2007-09-05 |
2009-03-12 |
Teva Pharmaceutical Industries, Ltd. |
Method of treating glaucoma using rasagiline
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
BRPI0905680A2
(pt)
*
|
2008-01-11 |
2015-07-07 |
Teva Pharma |
"composição farmacêutica de uma composição farmacêutica"
|
|
US20110027354A1
(en)
*
|
2008-04-01 |
2011-02-03 |
Kim Hyoung-Chun |
Anti-parkinsonian compounds
|
|
US20100008983A1
(en)
*
|
2008-06-10 |
2010-01-14 |
Muhammad Safadi |
Rasagiline soft gelatin capsules
|
|
AU2009258151A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline for Parkinson's disease modification
|
|
EA021472B1
(ru)
*
|
2008-06-19 |
2015-06-30 |
Тева Фармасьютикал Индастриз, Лтд. |
Способ получения и сушки твердого разагилина в форме основания
|
|
AU2009260733B2
(en)
*
|
2008-06-19 |
2015-01-29 |
Teva Pharmaceutical Industries, Ltd. |
Process for purifying rasagiline base
|
|
US20100189791A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline malate formulation
|
|
JP2012532843A
(ja)
|
2009-07-09 |
2012-12-20 |
ラティオファーム ゲーエムベーハー |
ラサギリンの塩およびその製剤
|
|
CA2789006C
(en)
|
2010-02-03 |
2018-11-27 |
Pharma Two B Ltd. |
Extended release formulations of rasagiline and uses thereof
|
|
JP2013533287A
(ja)
|
2010-07-27 |
2013-08-22 |
テバ ファーマシューティカル インダストリーズ リミティド |
嗅覚機能不全の処置のためのラサギリンの使用
|
|
WO2012015946A1
(en)
|
2010-07-27 |
2012-02-02 |
Teva Pharmaceutical Industries Ltd. |
Dispersion of rasagiline citrate
|
|
JP2014534197A
(ja)
|
2011-10-10 |
2014-12-18 |
テバ ファーマシューティカル インダストリーズ リミティド |
Ｒ（＋）−ｎ−メチル−プロパルギルアミノインダン
|
|
HK1200315A1
(en)
|
2011-10-10 |
2015-08-07 |
Teva Pharmaceutical Industries Ltd. |
R(+)-n-formyl-propargyl-aminoindan
|
|
WO2014028868A1
(en)
|
2012-08-17 |
2014-02-20 |
Teva Pharmaceutical Industries Ltd. |
Parenteral formulation of rasagiline
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|